Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 6/2018

27.10.2018 | Interesting Image

18F-FDG PET/CT detects Metastatic Renal Cell Carcinoma Masquerading as Primary Breast Malignancy

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

We present the case of a 36-year-old woman who underwent 18F-FDG PET/CT with suspicion of a primary breast malignancy. However, PET/CT detected an occult renal cell carcinoma with metastases to the thyroid, breast, lungs and lymph nodes. Thyroid and breast metastases are atypical metastatic sites of renal cell carcinoma. Breast metastases from extra mammary tissue are extremely rare, more so from renal cell carcinoma. Histopathologic confirmation of the breast lesions is imperative to avoid unnecessary mastectomy and imaging can help in raising the suspicion of metastatic involvement versus primary breast malignancy.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.CrossRef
2.
Zurück zum Zitat Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics. 2013;33:1691–716.CrossRef Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics. 2013;33:1691–716.CrossRef
3.
Zurück zum Zitat Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh Q-D, Briganti A, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23:973–80.CrossRef Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh Q-D, Briganti A, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23:973–80.CrossRef
4.
Zurück zum Zitat Sountoulides P, Metaxa L, Cindolo L. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep. 2011;5:429.CrossRef Sountoulides P, Metaxa L, Cindolo L. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep. 2011;5:429.CrossRef
5.
Zurück zum Zitat Bhoil A, Mittal BR, Bhattacharya A, Rane S, Nijhawan R, Gupta V. Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on 18F-FDG PET/CT. Clin Nucl Med. 2013;38:e474–6.CrossRef Bhoil A, Mittal BR, Bhattacharya A, Rane S, Nijhawan R, Gupta V. Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on 18F-FDG PET/CT. Clin Nucl Med. 2013;38:e474–6.CrossRef
6.
Zurück zum Zitat Pirola GM, Martorana E, Fidanza FA, Bonetti LR, Puliatti S, Bonora A, et al. Rare metastatic sites of renal cell carcinoma: urethra and spermatic cord. Riv Urol. 2016;83:214–7. Pirola GM, Martorana E, Fidanza FA, Bonetti LR, Puliatti S, Bonora A, et al. Rare metastatic sites of renal cell carcinoma: urethra and spermatic cord. Riv Urol. 2016;83:214–7.
7.
Zurück zum Zitat Aurangabadkar H, Ali Z. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan. Clin Nucl Med. 2013;38:e471–3.CrossRef Aurangabadkar H, Ali Z. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan. Clin Nucl Med. 2013;38:e471–3.CrossRef
8.
Zurück zum Zitat Vassalli L, Ferrari VD, Simoncini E, Rangoni G, Montini E, Marpicati P, et al. Solitary breast metastases from a renal cell carcinoma. Breast Cancer Res Treat. 2001;68:29–31.CrossRef Vassalli L, Ferrari VD, Simoncini E, Rangoni G, Montini E, Marpicati P, et al. Solitary breast metastases from a renal cell carcinoma. Breast Cancer Res Treat. 2001;68:29–31.CrossRef
9.
Zurück zum Zitat McLauglin SA, Thiel DD, Smith SL, Wehle MJ, Menke DM. Solitary breast mass as initial presentation of clinically silent metastatic renal cell carcinoma. Breast. 2006;15:426–8.CrossRef McLauglin SA, Thiel DD, Smith SL, Wehle MJ, Menke DM. Solitary breast mass as initial presentation of clinically silent metastatic renal cell carcinoma. Breast. 2006;15:426–8.CrossRef
10.
Zurück zum Zitat Mahrous M, Al Morsy W, Al-Hujaily A, Al-Sulimani S. Breast metastasis from renal cell carcinoma: rare initial presentation of disease recurrence after 5 years. J Breast Cancer. 2012;15:244–7.CrossRef Mahrous M, Al Morsy W, Al-Hujaily A, Al-Sulimani S. Breast metastasis from renal cell carcinoma: rare initial presentation of disease recurrence after 5 years. J Breast Cancer. 2012;15:244–7.CrossRef
11.
Zurück zum Zitat Alzaraa A, Vodovnik A, Montgomery H, Saeed M, Sharma N. Breast metastasis from a renal cell cancer. World J Surg Oncol. 2007;5:25.CrossRef Alzaraa A, Vodovnik A, Montgomery H, Saeed M, Sharma N. Breast metastasis from a renal cell cancer. World J Surg Oncol. 2007;5:25.CrossRef
12.
Zurück zum Zitat Falco G, Buggi F, Sanna PA, Dubini A, Folli S. Breast metastases from a Renal Cell Carcinoma. A case report and review of the literature. Int J Surg Case Rep. 2014;5:193–5.CrossRef Falco G, Buggi F, Sanna PA, Dubini A, Folli S. Breast metastases from a Renal Cell Carcinoma. A case report and review of the literature. Int J Surg Case Rep. 2014;5:193–5.CrossRef
13.
Zurück zum Zitat Kaushik A, Ho L. Thyroid metastasis from primary renal cell cancer on FDG PET/CT. Clin Nucl Med. 2011;36:56–8.CrossRef Kaushik A, Ho L. Thyroid metastasis from primary renal cell cancer on FDG PET/CT. Clin Nucl Med. 2011;36:56–8.CrossRef
Metadaten
Titel
18F-FDG PET/CT detects Metastatic Renal Cell Carcinoma Masquerading as Primary Breast Malignancy
Publikationsdatum
27.10.2018
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 6/2018
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-018-0553-6

Weitere Artikel der Ausgabe 6/2018

Nuclear Medicine and Molecular Imaging 6/2018 Zur Ausgabe